15 Mar 2010 Press Release
 

Globalpharma exhibits an extensive range of products at DUPHAT 2010

Globalpharma exhibits an extensive range of products at DUPHAT 2010
  • Text size
  •  
  •  

Dubai - UAE March 15, 2010: In a bid to increase awareness among health care Professionals on the effects of various medicines available, GlobalpharmaGlobalpharmaLoading..., a subsidiary of Dubai Investments PJSC and a leading player in the regional pharmaceutical industry, is participating at the Dubai International Pharmaceuticals and Technologies Conference Exhibition (DUPHAT) 2010, held at the Dubai International Convention and Exhibition Centre from March 15th to 17th 2010.

During the 3-day exhibition, GlobalpharmaGlobalpharmaLoading... showcases its extensive range of products including antibiotics, anti-rheumatics, antihypertensive, anti-ulcerant and vitamins as well as pain relievers. The GlobalpharmaGlobalpharmaLoading... booth is located at Stand 57 and 58 at the Sheikh Rashid Hall of the exhibition centre. This is the 4th consecutive year that GlobalpharmaGlobalpharmaLoading... is participating in DUPHAT.

"DUPHAT offers both local and international companies an opportunity to exhibit their products and services, thereby presenting us with an opportunity to exchange views and explore strategic business alliances and reinforce our relationship with health care professionals, and regulatory authorities from the UAE and other regional countries," said Jamil Akhtar, General Manager of GlobalpharmaGlobalpharmaLoading....

"GlobalpharmaGlobalpharmaLoading... researchers and scientists are constantly working towards discovering and developing Branded generic medicines of high quality which adhere to strict international standards. GlobalpharmaGlobalpharmaLoading...' long-term strategic plan is to increase its therapeutic medicine portfolio," Akhtar added.

GlobalpharmaGlobalpharmaLoading... is Dubai's first pharmaceutical manufacturing company, manufacturing and marketing pharmaceutical products in more than 20 countries across the Middle East, Africa and Far East. Established in 1998, the company has developed into a major player in the MEA pharmaceutical market, earning a reputation for quality and reliability.

-Ends-

Media Contacts:
Mitha Furtado
Headline Public Relations
Tel: 9714 - 2289655 Ext: 348
Fax: 9714 - 2282125
Email: mitha@headlinepr.com

© Press Release 2010

from Headline Public Relations
x DISCLAIMER

Zawya is a distributor (and not a publisher) of content supplied by third parties and subscribers. Any opinions, advice, statements, services, offers, or other information or content expressed or made available by those third parties, including information providers, subscribers or other users of the Service, are those of the respective author(s) or distributor(s) and not of the Company. The Company neither endorses nor is responsible for the accuracy or reliability of any opinion, advice or statement made on the Service by anyone other than authorized Service employee spokespersons while acting in their official capacities. The Company is not responsible for any infringement of intellectual property rights or breach of any applicable law or regulation, including regulation in relation to financial services or the distribution of financial products, defamation, data protection, telecommunications (including regulations relating to excessive use, spamming or other abusive activities) or obscene, offensive or illegal content). Under no circumstances will the Company be liable for any loss or damage caused by a member's reliance on information obtained through the Service. It is the responsibility of member to evaluate the accuracy, completeness or usefulness of any information, opinion, advice or other content available through the Service. Please seek the advice of professionals, as appropriate, regarding the evaluation of any specific information, opinion, advice or other content.

Read the full Member Agreement
http://www.zawya.com/legal/NewsLetter.cfm?name=disclaimer
Access to this article is subject to specific terms and condition.
 
 

Post a Comment

 
  • Comment Title (optional)
  • Express your views or tell us more about this article
  • First Name
  • Last Name
  • Email Address
  • Company Name (optional)
Leave this field empty
 
 
Zawya Comment Policy
 
  1. Zawya encourages you to add a comment to this discussion. You agree that when you add content to this discussion your comments will not:
    1.1   Contain any material which is libelous or defamatory of any person, is obscene, offensive, hateful or inflammatory or causes damage to the reputation of any person or organisation.
    1.2   Promote sexually explicit material, violence, discrimination based on race, sex, religion, nationality, disability, sexual orientation or age or any illegal activity.
    1.3   Be made in breach of any legal duty owed to a third party, such as a contractual duty or a duty of confidence.
    1.4   Be threatening, abuse or invade another's privacy, or cause annoyance, inconvenience or needless anxiety.
    1.5   Be used to impersonate any person, to misrepresent your identity or affiliation with any person, or be likely to deceive any person.
    1.6   Give the impression that they represent Zawya.
    1.7   Advocate, promote or assist any unlawful act such as (by way of example only) copyright infringement or computer misuse.
  2. The content posted on www.zawya.com is created by members of the public. The views expressed are theirs and unless specifically stated are not those of Zawya. Zawya reserves the right to review all comments prior to posting and edit or delete any contribution, but Zawya is not responsible for and can not be held liable for any content posted by members of the public on www.zawya.com.
  3. Zawya is not responsible for the availability or content of any third party sites that are accessible through www.zawya.com. Any links to third party websites from www.zawya.com do not amount to any endorsement of that site by Zawya and any use of that site by you is at your own risk.
  4. By submitting your comment, you hereby give Zawya the right, but not the obligation, to post, air, edit, exhibit, telecast, webcast, re-use, publish, reproduce, use, license, print, distribute or otherwise use your comments worldwide, in perpetuity.